Hyperfine HYPR
NASDAQ HYPR
$0.89 +0.02 (+2.30%)
At close: Oct 2, 2026 · 4:00 PM EDT

Hyperfine (HYPR) Gains from Sales and Divestitures (2023 - 2026)

Updated

Hyperfine (HYPR) posted Gains from Sales and Divestitures of -$1,000 for Q2 2026.

Analysis

Hyperfine (HYPR) Gains from Sales and Divestitures (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Hyperfine was -$126,000.

  • The Q2 2026 figure stands as the highest quarterly Gains from Sales and Divestitures since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Hyperfine 80.98 Mn -59.91 Mn 1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,000.00
Mar 31, 2026 -5,000.00
Sep 30, 2025 -120,000.00
Sep 30, 2024 -56,000.00
Sep 30, 2023 52,000.00
API Access

Hyperfine Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=HYPR&period=max&api_key=YOUR_API_KEY